NCT04834102 is a clinical trial of Blood Tests in Covid19, sponsored by Istanbul Medeniyet University.

Who is sponsoring NCT04834102?

NCT04834102 is sponsored by Istanbul Medeniyet University.

What drugs are being tested in NCT04834102?

Interventions in NCT04834102: Blood Tests.

What condition does NCT04834102 study?

NCT04834102 studies Covid19, Telogen Effluvium, SARS-CoV Infection, Alopecia.

Is NCT04834102 still recruiting?

NCT04834102 is currently status unknown. Last updated 6 April 2021.

Last reviewed 2021-04-06 · How we verify

NCT04834102

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COVID-19 Induced Telogen Effluvium

Status unknown Last updated 6 April 2021

What this trial tests

trial testing Blood Tests in Covid19 in 200 participants. Status unknown.

Timeline

27 January 2021

Primary endpoint
27 April 2021

27 April 2021

Quick facts

Lead sponsor	Istanbul Medeniyet University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	27 January 2021
Primary completion	27 April 2021
Estimated completion	27 April 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Blood Tests — full drug profile →

Conditions studied

Covid19 — all drugs for Covid19 →
Telogen Effluvium — all drugs for Telogen Effluvium →
SARS-CoV Infection — all drugs for SARS-CoV Infection →
Alopecia — all drugs for Alopecia →

Sponsor

Istanbul Medeniyet University

Who can join

18 and older, any sex, with Covid19 or Telogen Effluvium. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

COVID-19 induced telogen effluvium.
Aksoy H, Yıldırım UM, Ergen P, Gürel MS. · · 2021 · cited 30× · PMID 34708909 · DOI 10.1111/dth.15175

Verify or expand the search:

Other trials of Blood Tests

Trials testing the same drug.

NCT05378035 — DOAC in Chinese Patients With Atrial Fibrillation · recruiting
NCT04986917 — Laparoscopic Ventral Hernia Repair with Routine Defect Closure Using Su2ura® Approximation Device · NA · completed
NCT04827563 — Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib · terminated
NCT01492036 — Long-Term Follow-Up of Recipient of Gene Transfer Research · recruiting

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Istanbul Medeniyet University trials

Trials by the same sponsor.

NCT07478380 — Transcutaneous pO₂ Monitoring in PICU · recruiting
NCT07368244 — Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Co · recruiting
NCT07179731 — Comparison of the Effects of External Oblique Intercostal Plane Block, Subcostal Transverse Abdominis Plane Block, and T · NA · not yet recruiting
NCT07241455 — Validity of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx-TR) in Turkish Pediatric Intensive Care · completed
NCT07426497 — Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04834102 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Medeniyet University
Last refreshed: 6 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04834102.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing